Regulatory Compliance

Welcome To “The Clown World”

This begins a series of blog posts hopefully to highlight belief systems affecting healthcare seemingly in disarray…legislative boondoggles…proverbial tails wagging the dog. In a previous post, I proposed data that demonstrated the lack of evidence of the need for more continuing education – a la the “MATE Act”. Yet seemingly politicians ostensibly fawning for the

Welcome To “The Clown World” Read More »

The Disrupted Physician

In November 2015, a personal tragedy shattered Dr Ann Phelan-Adams, leading to months of grief, trauma, and a toxic mix of alcohol, antidepressants, and sedatives. With the support of family, friends, and therapists, she slowly recovered, but her medical board accused her of being impaired due to substance abuse and mental illness, threatening her license

The Disrupted Physician Read More »

On PHP Programs & A Follow-Up On SB 382…

NC Senate Bill 382 (SB 382) had several provisions but perhaps the one which drew the most attention was that which might empower the NC State Board of Dental Examiners (NCBDE) to compel licensees to undergo physical examination and/or testing without a court order. Ostensibly this bill might relate to mental health and substance abuse

On PHP Programs & A Follow-Up On SB 382… Read More »

NC Auditor Beth Wood Resigns Amid Controversy Following 2023 NC Medical Board Audit

In 2023 Beth Wood, the North Carolina State Auditor, initiated an audit of the North Carolina Medical Board (NCMB) that revealed significant issues in the board’s oversight of physician misconduct, including obstruction of access to investigation records. This raised concerns about the board’s effectiveness in protecting the public. Subsequently, Wood faced accusations of misusing state-owned

NC Auditor Beth Wood Resigns Amid Controversy Following 2023 NC Medical Board Audit Read More »

DEA Issues Guidance on Opioid Treatment Training for Medical Practitioners

The US Drug Enforcement Administration (DEA) has outlined an eight-hour training requirement on the treatment and management of opioid patients. The Medication Access and Training Expansion Act mandates the training for all DEA-registered providers, with the deadline for completion set for the date of a practitioner’s next scheduled DEA registration submission beginning on June 27. Graduates from medical and dental schools are exempt from the requirement. The training does not have to occur in one session, and courses previously undertaken in accordance with state-mandated continuing education will apply.

DEA Issues Guidance on Opioid Treatment Training for Medical Practitioners Read More »

FDA Approves OTC Naloxone

This article discusses the recent approval of the first over-the-counter naloxone nasal spray for use in reversing opioid overdoses. The U.S. Food and Drug Administration (FDA) has approved the first over-the-counter (OTC) naloxone nasal spray, Narcan, to help prevent opioid overdoses. The nasal spray is intended for use in adults and adolescents, and the FDA

FDA Approves OTC Naloxone Read More »

Shopping Cart
Scroll to Top
0